Search Result "JAK1 inhibitors"
Design and Synthesis of New JAK1 Inhibitors based on Sulfonamide-Triazine Conjugates
Journal: Current Computer-Aided Drug Design
Volume: 17 Issue: 7 Year: 2021 Page: 916-926
Author(s): Safa Daoud,Mutasem O. Taha
Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2017 Page: 268-294
Author(s): Eleni Vrontaki,Georgia Melagraki,Antreas Afantitis,Thomas Mavromoustakos,George Kollias
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Journal: Drug Metabolism Letters
Volume: 10 Issue: 1 Year: 2016 Page: 38-48
Author(s): Florence Namour,Julie Desrivot,Annegret Van der Aa,Pille Harrison,Gerben van`t Klooster,Chantal Tasset
An Update on JAK Inhibitors
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 10 Year: 2019 Page: 1806-1832
Author(s): Francesca Musumeci,Chiara Greco,Ilaria Giacchello,Anna Lucia Fallacara,Munjed M. Ibrahim,Giancarlo Grossi,Chiara Brullo,Silvia Schenone
Current Status in the Discovery of Covalent Janus Kinase 3 (JAK3) Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 18 Year: 2019 Page: 1531-1543
Author(s): Jun Dai,LiXi Yang,Glynn Addison
Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor forthe Treatment of Patients with Myelofibrosis
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1355-1360
Author(s): Surya K. De
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitorfor the Treatment of Atopic Dermatitis
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 38 Year: 2023 Page: 4278-4282
Author(s): Surya K. De
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 221-233
Author(s): Kakasaheb Ramoo Mahadik